- Release Date: 30/03/22 10:44
- Summary: Quarterly Activities/Appendix 5B Cash Flow Report
- Price Sensitive: Yes
- Download Document 1.32MB
- Forums
- ASX - By Stock
- ORM
- Ann: Quarterly Activities/Appendix 5B Cash Flow Report
Ann: Quarterly Activities/Appendix 5B Cash Flow Report
Featured News
Add ORM (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online